Alterity Therapeutics Ltd (ATHE)

1.3100
+0.0100(+0.77%)
After Hours
1.3000
-0.0100(-0.7634%)
- Real-time Data
  • Volume:
    88,348
  • Bid/Ask:
    1.3000/1.3200
  • Day's Range:
    1.2900 - 1.3200

ATHE Overview

Prev. Close
1.3
Day's Range
1.29-1.32
Revenue
14.62K
Open
1.32
52 wk Range
1.09-3.5
EPS
-0.43
Volume
88,348
Market Cap
57.17M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,493,504
P/E Ratio
-
Beta
1.55
1-Year Change
-35.47%
Shares Outstanding
2,406,874,578
Next Earnings Date
Dec. 01, 2021
What is your sentiment on Alterity Therapeutics Ltd?
or
Market is currently closed. Voting is open during market hours.

Alterity Therapeutics Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsBuyNeutralSellStrong BuySell
SummaryStrong BuyBuyNeutralBuySell

Alterity Therapeutics Ltd Company Profile

Alterity Therapeutics Ltd Company Profile

Employees
11

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson’s disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer’s disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.